Literature for inhibitor I17.002: elafin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, M Mutation, P Specificity, E Expression, U Therapeutic, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Li,X., Chen,L., Chen,N., Xu,L., Cui,X. and Wang,F.
    Elafin inhibits macrophage activation by blocking a chloride channel
    Biochim Biophys Acta Mol Basis Dis (2025) 1871, 167989-167989. PubMed  Europe PubMed DOI
  2. 2023
  3. Deraison,C., Bonnart,C., Langella,P., Roget,K. and Vergnolle,N.
    Elafin and its precursor trappin-2: What is their therapeutic potential for intestinal diseases?
    Br J Pharmacol (2023) 180, 144-160. PubMed  Europe PubMed DOI
  4. Lee,S., Yoo,I., Cheon,Y. and Ka,H.
    Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal-fetal interface in pigs
    Anim Biosci (2023) 36, 1034-1043. PubMed  Europe PubMed DOI
  5. 2022
  6. Wang,C., Liao,Y., He,W., Zhang,H., Zuo,D., Liu,W., Yang,Z., Qiu,J., Yuan,Y., Li,K., Zhang,Y., Wang,Y., Shi,Y., Qiu,Y., Gao,S., Yuan,Y. and Li,B.
    Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
    J Exp Clin Cancer Res (2022) 41, 104-104. PubMed  Europe PubMed DOI  PMC  EPMC
  7. 2021
  8. Douglas,T.C. and Hannila,S.S.
    Working from within: how secretory leukocyte protease inhibitor regulates the expression of pro-inflammatory genes
    Biochem Cell Biol (2021) PubMed  Europe PubMed DOI  V
  9. 2020
  10. Curciarello,R., Sobande,T., Jones,S., Giuffrida,P., Di Sabatino,A., Docena,G.H., Macdonald,T.T. and Kok,K.
    Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies
    J Inflamm Res (2020) 13, 233-243. PubMed  Europe PubMed DOI  PMC  EPMC
  11. Shu,L., Zhong,L., Xiao,Y., Wu,X., Liu,Y., Jiang,X., Tang,T., Hoo,R., Zhou,Z. and Xu,A.
    Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice
    Clin Sci (Lond) (2020) 134, 1679-1696. PubMed  Europe PubMed DOI
  12. 2019
  13. Geusau,A., Tzaneva,S., Petzelbauer,P., Mullegger,R., Brunner,P.M., Borik,L. and Mildner,M.
    Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipients
    Eur J Dermatol (2019) 29, 259-267. PubMed  Europe PubMed DOI
  14. 2017
  15. Han,W., Li,X., Zhang,H., Yu,B., Guo,C. and Deng,C.
    Recombinant human elafin promotes alveologenesis in newborn mice exposed to chronic hyperoxia
    Int J Biochem Cell Biol (2017) 92, 173-182. PubMed  Europe PubMed DOI  U
  16. Small,D.M., Doherty,D.F., Dougan,C.M., Weldon,S. and Taggart,C.C.
    The role of whey acidic protein four-disulfide-core proteins in respiratory health and disease
    Biol Chem (2017) 398, 425-440. PubMed  Europe PubMed DOI
  17. 2016
  18. Kaschwich,M., Lutzen,U., Zhao,Y., Tjiong,A., Marx,M., Haenisch,S., Wiedow,O., Preuss,S., Culman,J. and Zuhayra,M.
    Biodistribution and pharmacokinetics of the (99m)Tc labeled human elastase inhibitor, elafin, in rats
    Drug Metab Pharmacokinet (2016) 31, 146-155. PubMed  Europe PubMed DOI  U
  19. Loth,K., Alami,S.A., Habes,C., Garrido,S., Aucagne,V., Delmas,A.F., Moreau,T., Zani,M.L. and Landon,C.
    Complete 1H, 15N and 13C assignment of trappin-2 and (1)H assignment of its two domains elafin and cementoin
    Biomol NMR Assign (2016) 10, 223-226. PubMed  Europe PubMed DOI  S
  20. Muto,J., Fujimoto,N., Ono,K., Kobayashi,T., Chen,K.R., Suzuki,S., Wachi,H. and Tajima,S.
    Deposition of elafin in the involved vascular wall of neutrophil-mediated cutaneous vasculitis
    J Eur Acad Dermatol Venereol (2016) 30, 1544-1549. PubMed  Europe PubMed DOI
  21. 2015
  22. Alam,S.R., Lewis,S.C., Zamvar,V., Pessotto,R., Dweck,M.R., Krishan,A., Goodman,K., Oatey,K., Harkess,R., Milne,L., Thomas,S., Mills,N.M., Moore,C., Semple,S., Wiedow,O., Stirrat,C., Mirsadraee,S., Newby,D.E. and Henriksen,P.A.
    Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial
    Heart (2015) 101, 1639-1645. PubMed  Europe PubMed DOI  U
  23. Caruso,J.A., Akli,S., Pageon,L., Hunt,K.K. and Keyomarsi,K.
    The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase
    Oncogene (2015) 34, 3556-3567. PubMed  Europe PubMed DOI
  24. Chun,H.J. and Yu,P.B.
    Elafin in pulmonary arterial hypertension. Beyond targeting elastases
    Am J Respir Crit Care Med (2015) 191, 1217-1219. PubMed  Europe PubMed DOI  U
  25. Feng,Y., Doberstein,K. and Drapkin,R.
    Elafin: a double agent in breast and ovarian cancer
    Oncoscience (2015) 2, 793-794. PubMed  Europe PubMed DOI
  26. Jiang,X., Nguyen,T.T., Tian,W., Sung,Y.K., Yuan,K., Qian,J., Rajadas,J., Sallenave,J.M., Nickel,N.P., de Jesus Perez,V., Rabinovitch,M. and Nicolls,M.R.
    Cyclosporine does not prevent microvascular loss in transplantation but can synergize with a neutrophil elastase inhibitor, elafin, to maintain graft perfusion during acute rejection
    Am J Transplant (2015) 15, 1768-1781. PubMed  Europe PubMed DOI  U
  27. Kav,T.
    Use of elafin in celiac disease
    Turk J Gastroenterol (2015) 26, 93-94. PubMed  Europe PubMed DOI  U
  28. Small,D.M., Zani,M.L., Quinn,D.J., Dallet-Choisy,S., Glasgow,A.M., O'Kane,C., McAuley,D.F., McNally,P., Weldon,S., Moreau,T. and Taggart,C.C.
    A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation
    Mol Ther (2015) 23, 24-31. PubMed  Europe PubMed DOI  U
  29. 2014
  30. Galipeau,H.J., Wiepjes,M., Motta,J.P., Schulz,J.D., Jury,J., Natividad,J.M., Pinto-Sanchez,I., Sinclair,D., Rousset,P., Martin-Rosique,R., Bermudez-Humaran,L., Leroux,J.C., Murray,J.A., Smecuol,E., Bai,J.C., Vergnolle,N., Langella,P. and Verdu,E.F.
    Novel role of the serine protease inhibitor elafin in gluten-related disorders
    Am J Gastroenterol (2014) 109, 748-756. PubMed  Europe PubMed DOI
  31. Tejera,P., O'Mahony,D.S., Owen,C.A., Wei,Y., Wang,Z., Gupta,K., Su,L., Villar,J., Wurfel,M. and Christiani,D.C.
    Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome
    Am J Respir Cell Mol Biol (2014) 51, 262-272. PubMed  Europe PubMed DOI  M
  32. 2012
  33. Greenhill,C.
    IBD: elafin - a potential IBD therapy
    Nat Rev Gastroenterol Hepatol (2012) 9, 686-686. PubMed  Europe PubMed DOI  U
  34. Hilgendorff,A., Parai,K., Ertsey,R., Juliana Rey-Parra,G., Thebaud,B., Tamosiuniene,R., Jain,N., Navarro,E.F., Starcher,B.C., Nicolls,M.R., Rabinovitch,M. and Bland,R.D.
    Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth
    Am J Physiol Lung Cell Mol Physiol (2012) 303, L215-L227. PubMed  Europe PubMed DOI
  35. 2011
  36. Hilgendorff,A., Parai,K., Ertsey,R., Jain,N., Navarro,E.F., Peterson,J.L., Tamosiuniene,R., Nicolls,M.R., Starcher,B.C., Rabinovitch,M. and Bland,R.D.
    Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice
    Am J Respir Crit Care Med (2011) 184, 537-546. PubMed  Europe PubMed DOI  U
  37. Scott,A., Weldon,S. and Taggart,C.C.
    SLPI and elafin: multifunctional antiproteases of the WFDC family
    Biochem Soc Trans (2011) 39, 1437-1440. PubMed  Europe PubMed DOI
  38. Shaw,L. and Wiedow,O.
    Therapeutic potential of human elafin
    Biochem Soc Trans (2011) 39, 1450-1454. PubMed  Europe PubMed DOI  U
  39. Xu,X.Y., Yuan,D.M. and Zhou,X.D.
    [Effects of recombinant human elafin gene transfection on lipopolysaccharide-induced airway mucous hypersecretion]
    Zhonghua Yi Xue Za Zhi (2011) 91, 340-344. PubMed  Europe PubMed  U
  40. Yu,H.M., Li,Q., Zhou,X.D., Perelman,J.M. and Kolosov,V.P.
    Expression of recombinant fusion protein BoNT-LH (N)-elafin in Pichia pastoris and activity of expressed product
    Chin J Biol (2011) 24, 389-393.  U
  41. Zani,M.L., Tanga,A., Saidi,A., Serrano,H., Dallet-Choisy,S., Baranger,K. and Moreau,T.
    SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions
    Biochem Soc Trans (2011) 39, 1441-1446. PubMed  Europe PubMed DOI  U
  42. 2010
  43. Caruso,J.A., Hunt,K.K. and Keyomarsi,K.
    The neutrophil elastase inhibitor elafin triggers Rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer
    Cancer Res (2010) 70, 7125-7136. PubMed  Europe PubMed DOI
  44. Clauss,A., Ng,V., Liu,J., Piao,H., Russo,M., Vena,N., Sheng,Q., Hirsch,M.S., Bonome,T., Matulonis,U., Ligon,A.H., Birrer,M.J. and Drapkin,R.
    Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival
    Neoplasia (2010) 12, 161-172. PubMed  Europe PubMed DOI  PMC  EPMC
  45. Guyot,N., Bergsson,G., Butler,M.W., Greene,C.M., Weldon,S., Kessler,E., Levine,R.L., O'Neill,S.J., Taggart,C.C. and McElvaney,N.G.
    Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases
    Biol Chem (2010) 391, 705-716. PubMed  Europe PubMed DOI  P
  46. Li,Q., Zhou,X., Nie,X. and Yang,J.
    The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm
    Respiration (2010) 79, 68-75. PubMed  Europe PubMed DOI
  47. Li,Q., Zhou,X.D., Xu,X.Y. and Yang,J.
    Recombinant human elafin protects airway epithelium integrity during inflammation
    Mol Biol Rep (2010) 37, 2981-2988. PubMed  Europe PubMed DOI  U
  48. Sallenave,J.M.
    Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity
    Am J Respir Cell Mol Biol (2010) 42, 635-643. PubMed  Europe PubMed DOI  V
  49. Yu,K.S., Lee,Y., Kim,C.M., Park,E.C., Choi,J., Lim,D.S., Chung,Y.H. and Koh,S.S.
    The protease inhibitor, elafin, induces p53-dependent apoptosis in human melanoma cells
    Int J Cancer (2010) 127, 1308-1320. PubMed  Europe PubMed DOI
  50. 2009
  51. Iqbal,S.M., Ball,T.B., Levinson,P., Maranan,L., Jaoko,W., Wachihi,C., Pak,B.J., Podust,V.N., Broliden,K., Hirbod,T., Kaul,R. and Plummer,F.A.
    Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition
    AIDS (2009) 23, 1669-1677. PubMed  Europe PubMed DOI
  52. Marischen,L., Wesch,D., Schroder,J.M., Wiedow,O. and Kabelitz,D.
    Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin
    Scand J Immunol (2009) 70, 547-552. PubMed  Europe PubMed DOI
  53. Tejera,P., Wang,Z., Zhai,R., Su,L., Sheu,C.C., Taylor,D.M., Chen,F., Gong,M.N., Thompson,B.T. and Christiani,D.C.
    Genetic polymorphisms of peptidase inhibitor 3 (elafin) are associated with acute respiratory distress syndrome
    Am J Respir Cell Mol Biol (2009) 41, 696-704. PubMed  Europe PubMed DOI  M
  54. 2008
  55. Baranger,K., Zani,M.L., Chandenier,J., Dallet-Choisy,S. and Moreau,T.
    The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function
    FEBS J (2008) 275, 2008-2020. PubMed  Europe PubMed DOI
  56. Bellemare,A., Vernoux,N., Morisset,D. and Bourbonnais,Y.
    Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media
    Antimicrob Agents Chemother (2008) 52, 483-490. PubMed  Europe PubMed DOI  PMC  EPMC
  57. Moreau,T., Baranger,K., Dade,S., Dallet-Choisy,S., Guyot,N. and Zani,M.L.
    Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family
    Biochimie (2008) 90, 284-295. PubMed  Europe PubMed DOI
  58. 2007
  59. Doucet,A., Bouchard,D., Janelle,M.F., Bellemare,A., Gagne,S., Tremblay,G.M. and Bourbonnais,Y.
    Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema
    Biochem J (2007) 405, 455-463. PubMed  Europe PubMed DOI  PMC  EPMC
  60. Muto,J., Kuroda,K., Wachi,H., Hirose,S. and Tajima,S.
    Accumulation of elafin in actinic elastosis of sun-damaged skin: elafin binds to elastin and prevents elastolytic degradation
    J Invest Dermatol (2007) 127, 1358-1366. PubMed  Europe PubMed DOI
  61. 2006
  62. [YEAR:15-9-2006]Butler,M.W., Robertson,I., Greene,C.M., O'Neill,S.J., Taggart,C.C. and McElvaney,N.G.
    Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappa B activation via an effect on the ubiquitin-proteasome pathway
    J Biol Chem (15-9-2006) 281, 34730-34735. PubMed  Europe PubMed DOI
  63. Janelle,M.F., Doucet,A., Bouchard,D., Bourbonnais,Y. and Tremblay,G.M.
    Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
    Biol Chem (2006) 387, 903-909. PubMed  Europe PubMed DOI
  64. [YEAR:19-1-2006]Roghanian,A., Williams,S.E., Sheldrake,T.A., Brown,T.I., Oberheim,K., Xing,Z., Howie,S.E. and Sallenave,J.M.
    The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity
    Am J Respir Cell Mol Biol (19-1-2006) 34, 634-642. PubMed  Europe PubMed DOI
  65. 2005
  66. [YEAR:29-11-2005]Guyot,N., Zani,M.L., Maurel,M.C., Dallet-Choisy,S. and Moreau,T.
    Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase
    Biochemistry (29-11-2005) 44, 15610-15618. PubMed  Europe PubMed DOI
  67. Guyot,N., Zani,M.L., Berger,P., Dallet-Choisy,S. and Moreau,T.
    Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin
    Biol Chem (2005) 386, 391-399. PubMed  Europe PubMed DOI
  68. Nobar,S.M., Zani,M.L., Boudier,C., Moreau,T. and Bieth,J.G.
    Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3
    FEBS J (2005) 272, 5883-5893. PubMed  Europe PubMed DOI
  69. 2004
  70. [YEAR:3-8-2004]Brown,T.I., Mistry,R., Collie,D.D., Tate,S. and Sallenave,J.M.
    Trappin ovine molecule (TOM), the ovine ortholog of elafin, is an acute phase reactant in the lung
    Physiol Genomics (3-8-2004) 19, 11-21. PubMed  Europe PubMed DOI
  71. [YEAR:10-9-2004]Henriksen,P.A., Devitt,A., Kotelevtsev,Y. and Sallenave,J.M.
    Gene delivery of the elastase inhibitor elafin protects macrophages from neutrophil elastase-mediated impairment of apoptotic cell recognition
    FEBS Lett (10-9-2004) 574, 80-84. PubMed  Europe PubMed DOI
  72. Ohta,K., Nakajima,T., Cheah,A.Y., Zaidi,S.H., Kaviani,N., Dawood,F., You,X.M., Liu,P., Husain,M. and Rabinovitch,M.
    Elafin-overexpressing mice have improved cardiac function after myocardial infarction
    Am J Physiol Heart Circ Physiol (2004) 287, H286-H292. PubMed  Europe PubMed DOI
  73. Zani,M.L., Nobar,S.M., Lacour,S.A., Lemoine,S., Boudier,C., Bieth,J.G. and Moreau,T.
    Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris
    Eur J Biochem (2004) 271, 2370-2378. PubMed  Europe PubMed DOI
  74. 2003
  75. King,A.E., Critchley,H.O., Sallenave,J.M. and Kelly,R.W.
    Elafin in human endometrium: an antiprotease and antimicrobial molecule expressed during menstruation
    J Clin Endocrinol Metab (2003) 88, 4426-4431. PubMed  Europe PubMed DOI
  76. 2002
  77. [YEAR:15-11-2002]Clauss,A., Lilja,H. and Lundwall,A.
    A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein
    Biochem J (15-11-2002) 368, 233-242. PubMed  Europe PubMed DOI  PMC  EPMC
  78. Sallenave,J.M.
    Antimicrobial activity of antiproteinases
    Biochem Soc Trans (2002) 30, 111-115. PubMed  Europe PubMed
  79. Tremblay,G.M., Vachon,E., Larouche,C. and Bourbonnais,Y.
    Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2)
    Chest (2002) 121, 582-588. PubMed  Europe PubMed DOI
  80. Vachon,E., Bourbonnais,Y., Bingle,C.D., Rowe,S.J., Janelle,M.F. and Tremblay,G.M.
    Anti-inflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation
    Biol Chem (2002) 383, 1249-1256. PubMed  Europe PubMed DOI
  81. [YEAR:29-1-2002]Zaidi,S.H., You,X.M., Ciura,S., Husain,M. and Rabinovitch,M.
    Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension
    Circulation (29-1-2002) 105, 516-521. PubMed  Europe PubMed DOI
  82. 2001
  83. Ying,Q.L. and Simon,S.R.
    Kinetics of the inhibition of proteinase 3 by elafin
    Am J Respir Cell Mol Biol (2001) 24, 83-89. PubMed  Europe PubMed DOI
  84. 2000
  85. Bourbonnais,Y., Larouche,C. and Tremblay,G.M.
    Production of full-length human pre-elafin, an elastase specific inhibitor, from yeast requires the absence of a functional yapsin 1 (Yps1p) endoprotease
    Protein Expr Purif (2000) 20, 485-491. PubMed  Europe PubMed DOI  E
  86. Cowan,K.N., Heilbut,A., Humpl,T., Lam,C., Ito,S. and Rabinovitch,M.
    Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
    Nat Med (2000) 6, 698-702. PubMed  Europe PubMed DOI
  87. [YEAR:7-11-2000]O'Blenes,S.B., Zaidi,S.H.E., Cheah,A.Y.L., McIntyre,B., Kaneda,Y. and Rabinovitch,M.
    Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration
    Circulation (7-11-2000) 102 Suppl 3, 289-295. PubMed  Europe PubMed
  88. 1997
  89. Francart,C., Dauchez,M., Alix,A.J. and Lippens,G.
    Solution structure of r-elafin, a specific inhibitor of elastase
    J Mol Biol (1997) 268, 666-677. PubMed  Europe PubMed DOI
  90. 1996
  91. Lundwall,A. and Ulvsback,M.
    The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family
    Biochem Biophys Res Commun (1996) 221, 323-327. PubMed  Europe PubMed DOI
  92. [YEAR:10-9-1996]Tsunemi,M., Matsuura,Y., Sakakibara,S. and Katsube,Y.
    Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution
    Biochemistry (10-9-1996) 35, 11570-11576. PubMed  Europe PubMed DOI  S
  93. 1994
  94. Nara,K., Ito,S., Ito,T., Suzuki,Y., Ghoneim,M.A., Tachibana,S. and Hirose,S.
    Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin"
    J Biochem (1994) 115, 441-448. PubMed  Europe PubMed
  95. 1993
  96. [YEAR:5-7-1993]Tsunemi,M., Matsuura,Y., Sakakibara,S. and Katsube,Y.
    Crystallization of a complex between an elastase-specific inhibitor elafin and porcine pancreatic elastase
    J Mol Biol (5-7-1993) 232, 310-311. PubMed  Europe PubMed DOI
  97. [YEAR:23-2-1993]Ying,Q.L. and Simon,S.R.
    Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin
    Biochemistry (23-2-1993) 32, 1866-1874. PubMed  Europe PubMed
  98. 1991
  99. Wiedow,O., Luademann,J. and Utecht,B.
    Elafin is a potent inhibitor of proteinase 3
    Biochem Biophys Res Commun (1991) 174, 6-10. PubMed  Europe PubMed DOI
  100. 1990
  101. [YEAR:5-9-1990]Wiedow,O., Schroder,J.M., Gregory,H., Young,J.A. and Christophers,E.
    Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence
    J Biol Chem (5-9-1990) 265, 14791-14795. PubMed  Europe PubMed